כנס IATI-BIOMED יציין השנה 15 להיווסדו שורה ארוכה של מדענים וחברות מרחבי העולם ישתתפו השנה בכנס הביומד IATI BIOMED שיערך בתל אביב זו השנה ה-15 ברציפות כנסIATI BIOMED, אחד מהאירועים המובילים בתחום הביומד והאירוע הגדול של תעשיית מדעי החיים הישראלית, ייערך זו השנה ה-15, בין התאריכים 24 – 26 במאי, 2016, בתל אביב. האירוע, שמהווה [...]
האם הדרך המהירה לרזות כוללת השתלת צואה? מחקר ישראלי שמתקיים בימים אלה מנסה לבדוק האם פרוצדורה של השתלת צואה שתשנה את מאזן החיידקים במעי, יכולה לגרום גם להרזיה. אם המחקר יצליח הוא עשוי לפתוח פתח למציאת תרופות נגד השמנה קחו נשימה עמוקה לפני שאתם קוראים את זה: האם יכול להיות שהדרך הכי יעילה להרזות כוללת [...]
The list of cancers that can be treated by immunotherapy keeps growing The "Promise of Immuno-oncology" track at IATI-Biomed, on May 24, in Tel Aviv will showcase Israel's innovations in the field, featuring Compugen, BioLineRx, Vascular BioGenics, Silenseed, Kahr Medical, Efranat, and Immune Pharmaceuticals. In immunotherapy, T-cells from a cancer patient can be genetically [...]
Uncovering risks and opportunities: Insights into the U.S. Regulatory Environment for Medical Devices Bringing innovative medical devices to market in the U.S. requires navigating the choppy waters of FDA regulations. There are governing laws and regulations for every stage of the product life cycle—from product development and clinical trials through premarket submission reviews [...]
Dr. Stephen E. Yoder is among the speakers at the “Gene Editing and Gene Therapy” track, at the IATI-Biomed conference, May 24-26, Tel Aviv. Stephen E. Yoder, MD, Head of Specialty Pharmaceuticals Search & Evaluation, Business Development at Bristol-Myers Squibb Gene editing, the site specific manipulation of the genome, is opening up new [...]
Come hear Dr. Miro Venturi, at the IATI-Biomed conference, May 24-26, Tel Aviv, on “The importance of diagnostics and molecular information in the patient's journey: realizing the promise of personalized healthcare". Miro Venturi, PhD, Global Head Diagnostics Biomarkers, Hoffmann-la Roche The challenge of providing sustainable and effective healthcare to a growing and [...]
Come hear Dr. Anthony Muslin, on “Opportunities and Challenges in the Cardiovascular Biopharma Market”, at the IATI-Biomed 2016 conference, May 24-26. Clinical developments over the last 20 years have led to 15% reduction in cardiovascular death in the US, but it is still the leading cause of death worldwide. With the continued trends [...]
Despite optimism, bitter truth is that over 99 percent of clinical trials for Alzheimer’s treatments end in failure. A lab mouse in New York. The mice in the Weizmann study did better when receiving the cancer drug at night. Bloomberg A new drug under development by Israeli scientists to fight Alzheimer’s disease has led to [...]
Cancer immunotherapy has emerged as a new approach to treat cancer that is promising to revolutionize cancer treatment and survival outcomes. Cancer immunotherapy utilizes the innate powers of the immune system to fight cancer, and with its advent we are witnessing long-lasting remissions, with minimal side effects, in some patients with advanced cancers. Are [...]
It is time for you to meet our Exhibitors. More than 90 companies are exhibiting this year with another 45 Start-Ups to be announced soon! The Start-up Area is one of the highlights of the conference, dedicated to providing a powerful, high-end platform for maximum exposure. Register now! The Early Registration Finish Soon! [...]